PAM
IDYA icon

Panagora Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Panagora Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,372
Closed -$336K – 1480
2022
Q2 		$336K Sell
24,372
-534
-2% -$5.94K ﹤0.01% 1283
2022
Q1 		$279K Hold
24,906
– – ﹤0.01% 1373
2021
Q4 		$589K Buy
24,906
+295
+1% +$6.85K ﹤0.01% 1143
2021
Q3 		$627K Buy
24,611
+23,996
+3,902% +$560K ﹤0.01% 1205
2021
Q2 		$13K Sell
615
-1,116
-64% -$22.9K ﹤0.01% 2218
2021
Q1 		$41K Buy
1,731
+1,083
+167% +$20.9K ﹤0.01% 2215
2020
Q4 		$9K Sell
648
-4,654
-88% -$63K ﹤0.01% 2313
2020
Q3 		$67K Buy
5,302
+1,780
+51% +$22K ﹤0.01% 1945
2020
Q2 		$50K Buy
3,522
+3,362
+2,101% +$26.5K ﹤0.01% 1975
2020
Q1 		$1K Hold
160
– – ﹤0.01% 2441
2019
Q4 		$1K Buy
+160
New +$1.14K ﹤0.01% 2400

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Panagora Asset Management's IDYA Position: Q3 2022 in Review

Panagora Asset Management sold out of IDEAYA Biosciences (IDYA) in Q3 2022, closing a stake of 24,372 shares — an estimated $336K sold.

Panagora Asset Management first reported a position in IDYA in Q4 2019 and held it in 11 quarters. The position peaked at $627K in Q3 2021. 112 funds tracked by Wall St. Rank hold IDYA as of Q3 2022.

  • Panagora Asset Management reported no remaining IDEAYA Biosciences position as of Q3 2022 after selling out during the quarter.
  • Panagora Asset Management sold 24,372 IDEAYA Biosciences shares in Q3 2022, an estimated $336K.
  • Panagora Asset Management first reported a position in IDEAYA Biosciences in Q4 2019 and held it in 11 quarters.
  • Panagora Asset Management's IDEAYA Biosciences position peaked at $627K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.